Historically, the NRF2-KEAP1 pathway has been the focus of extensive research aimed at assessing its potential role in human chronic diseases characterized by alterations of the redox homeostasis such as diabetes, cardiovascular diseases, neurodegenerative diseases and cancer. The gene discussed is KEAP1; the disease is cancer.